U.S. flag

An official website of the United States government

NM_017849.4(TMEM127):c.556G>C (p.Ala186Pro) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 16, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002343526.3

Allele description [Variation Report for NM_017849.4(TMEM127):c.556G>C (p.Ala186Pro)]

NM_017849.4(TMEM127):c.556G>C (p.Ala186Pro)

Gene:
TMEM127:transmembrane protein 127 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q11.2
Genomic location:
Preferred name:
NM_017849.4(TMEM127):c.556G>C (p.Ala186Pro)
HGVS:
  • NC_000002.12:g.96253969C>G
  • NG_027695.1:g.17045G>C
  • NM_001193304.3:c.556G>C
  • NM_017849.4:c.556G>CMANE SELECT
  • NP_001180233.1:p.Ala186Pro
  • NP_060319.1:p.Ala186Pro
  • NP_060319.1:p.Ala186Pro
  • LRG_528t1:c.556G>C
  • LRG_528:g.17045G>C
  • LRG_528p1:p.Ala186Pro
  • NC_000002.11:g.96919707C>G
  • NM_017849.3:c.556G>C
Protein change:
A186P
Links:
dbSNP: rs764012422
NCBI 1000 Genomes Browser:
rs764012422
Molecular consequence:
  • NM_001193304.3:c.556G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_017849.4:c.556G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002650915Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Mar 16, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma.

Ben Aim L, Pigny P, Castro-Vega LJ, Buffet A, Amar L, Bertherat J, Drui D, Guilhem I, Baudin E, Lussey-Lepoutre C, Corsini C, Chabrier G, Briet C, Faivre L, Cardot-Bauters C, Favier J, Gimenez-Roqueplo AP, Burnichon N.

J Med Genet. 2019 Aug;56(8):513-520. doi: 10.1136/jmedgenet-2018-105714. Epub 2019 Mar 15.

PubMed [citation]
PMID:
30877234

Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.

Armaiz-Pena G, Flores SK, Cheng ZM, Zhang X, Esquivel E, Poullard N, Vaidyanathan A, Liu Q, Michalek J, Santillan-Gomez AA, Liss M, Ahmadi S, Katselnik D, Maldonado E, Salgado SA, Jimenez C, Fishbein L, Hamidi O, Else T, Lechan R, Tischler AS, Benn DE, et al.

J Clin Endocrinol Metab. 2021 Jan 1;106(1):e350-e364. doi: 10.1210/clinem/dgaa741.

PubMed [citation]
PMID:
33051659
PMCID:
PMC7765648

Details of each submission

From Ambry Genetics, SCV002650915.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The p.A186P variant (also known as c.556G>C), located in coding exon 3 of the TMEM127 gene, results from a G to C substitution at nucleotide position 556. The alanine at codon 186 is replaced by proline, an amino acid with highly similar properties. This alteration has been identified in multiple individuals diagnosed with pheochromocytoma (Ben Aim L et al. J Med Genet, 2019 Aug;56:513-520; Armaiz-Pena G et al. J Clin Endocrinol Metab, 2021 Jan;106:e350-e364). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024